Efficacy of Botulinum toxin A on Post herpetic Neuralgia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT138812033396N1

Enrollment

Registered

2010-05-19

Start date

2009-01-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic Neuralgia. Postherpetic Neuralgia

Interventions

Intradermal injection of botolinum toxin A (15 units /every 10cm² of body involved).

Treatment - Drugs

Intradermal injection of botolinum toxin A (15 units /every 10cm² of body involved)

Eligibility

Sex/Gender

All

Age

18 Years to 149 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age>18, pain>1month, sex:both Exclusion criteria: history of botolinium toxin A injection for this pain, coagulopathy, topical infection, allergy to topical anesthetics, tumor in site of lesion, sepsis.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 2 days, 2 weeks, 1 month after injection. Method of measurement: Visual Analogue Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.MohamadReza Emad

Shiraz University of Medical Sciences - Department of Physical Medicine and Rehabilitation

emadm@sums.ac.ir+98 71 1231 9040

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026